Clinical trial
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma…
NCT00436436 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00436436 |
|---|---|
| Title | O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy |
| Official title | A Phase 2 Study of O-Benzylguanine (O-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | O6-benzylguanine, temozolomide |
| Enrollment | 12 |
| Start date | Nov 13, 2006 |
| Primary completion | Mar 15, 2010 |
| Completion | Apr 14, 2010 |
| First posted | Feb 19, 2007 |
| Last update posted | Mar 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: